SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.210-2.4%1:20 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BoredMember who wrote (12484)12/5/2019 2:47:24 PM
From: HardToFind   of 12873
 
Do NNVC's Drugs Really Work?
I do not believe the science ever worked (and if you ask any credible medical doctor they will tell you the same thing).
It should be interesting in the next year or so whether or not Diwan/NNVC is able to get IND (investigational new drug) clearance from the FDA. If so, that would indicate that the FDA believed the drug at least enough data that indicated some evidence of safety and efficacy in animal (or in the case of VZV, SUNY's cadaver skin model) testing to justify testing in humans.

Then, if they can get a research institution's IRB (internal review board) to agree to testing (i.e., human clinical trials), they would be indicating that in the IRB's opinion, the potential patient benefit appears to outweigh the risks.

Granted...this hasn't happened yet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News